Pyoderma gangrenosum care at Mayo Clinic

Pyoderma gangrenosum is a rare condition that can have widespread effects on your body. Proper diagnosis and treatment are key to recovery. Your doctors will work with you to develop a comprehensive treatment plan that meets your needs and takes into consideration possible side effects of each treatment option. Your care team will follow up with you to monitor your response to treatment.

  • Accurate diagnosis. Similar-appearing ulcers can be caused by many diseases. Mayo Clinic specialists work as an integrated team to arrive at an accurate diagnosis so that you get exactly the care you need.
  • Team approach. You may need treatment for other conditions related to pyoderma gangrenosum, such as chronic pain or depression. Your Mayo Clinic dermatologists can work with other Mayo Clinic specialists and your primary care doctor to ensure you get the care you need.

Expertise and rankings

Mayo has a long experience in diagnosing and treating this rare disease. Pyoderma gangrenosum was first identified by Mayo doctors more than 80 years ago. More recently, Mayo clinicians researched the extent to which pyoderma gangrenosum is misdiagnosed and the types of treatment that work best for the condition.

July 28, 2017
  1. Dabade TS, et al. Diagnosis and treatment of the neutrophilic dermatoses (pyoderma gangrenosum, Sweet's syndrome). Dermatologic Therapy. 2011;24:273.
  2. Miller J, et al. Pyoderma gangrenosum: A review and update on new therapies. Journal of the American Academy of Dermatology. 2010;62:646.
  3. AskMayoExpert. Pyoderma gangrenosum. Rochester, Minn.: Mayo Foundation for Medical Education and Research; 2014.
  4. Shahi V, et al. Pyoderma gangrenosum associated with solid organ malignancies. International Journal of Dermatology. 2015;54:e351.
  5. Bolognia J, et al., eds. Neutrophilic dermatoses. In: Dermatology. 3rd ed. Philadelphia: Elsevier Saunders; 2012.
  6. Ferri FF. Pyoderma gangrenosum. In: Ferri's Clinical Advisor 2016. Philadelphia, Pa.: Mosby Elsevier; 2016. Accessed Sept. 24, 2015.
  7. Wolff K, et al. Neutrophil-mediated diseases. In: Fitzpatrick's Color Atlas and Synopsis of Clinical Dermatology. 7th ed. New York, N.Y.: The McGraw-Hill Companies; 2013. Accessed Sept. 29, 2015.
  8. Goldsmith LA, et al., eds. Pyoderma gangrenosum. In: Fitzpatrick's Dermatology in General Medicine. 8th ed. New York, N.Y.: The McGraw-Hill Companies; 2012. Accessed Sept. 29, 2015.
  9. Stanislav N, et al. Postoperative pyoderma gangrenosum (PG): The Mayo Clinic experience of 20 years from 1994 through 2014. Journal of the American Academy of Dermatology. 2015;73:615.
  10. Braswel SF, et al. Pathophysiology of pyoderma gangrenosum (PG): An updated review. Journal of the American Academy of Dermatology. 2015;73:691.
  11. Cabalag MS, et al. Inpatient management of pyoderma gangrenosum: Treatments, outcomes and clinical implications. Annals of Plastic Surgery. 2015;74:354.
  12. AskMayoExpert. Skin grafts. Rochester, Minn.: Mayo Foundation for Medical Education and Research; 2014.
  13. Stair-Buchmann ME, et al. Pyoderma gangrenosum: A difficult diagnosis best managed in a burn treatment center. Journal of Burn Care Research. 2015;36:3190.
  14. Armstrong DG, et al. Basic principles of wound management. Accessed Sept. 30, 2015.
  15. Okhovat JP, et al. JAMA Dermatology Patient Page: Pyoderma gangrenosum. JAMA Dermatology. 2014;150:1032.
  16. DeFilipps EM, et al. The genetics of pyoderma gangrenosum and implications for treatment: A systematic review. British Journal of Dermatology. 2015;172:1487.
  17. AskMayoExpert. Skin ulcers. Rochester, Minn.: Mayo Foundation for Medical Education and Research; 2015.